
Short- and long-term effects of neonatal pharmacotherapy with epigallocatechin-3-gallate on hippocampal development in the Ts65Dn mouse model of Down syndrome
Keywords: هلیوس; BrdU; 5-bromo-2-deoxyuridine; DG; dentate gyrus; DS; Down syndrome; DYRK1A; dual specificity tyrosine phosphorylation-regulated kinase 1A; EGCG; epigallocatechin-3-gallate; GFAP; glial fibrillary acidic protein; H; hilus; IHC; immunohistochemistry; LSD; L